Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001415889-24-005251

CHIEF FINANCIAL OFFICER acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coveney Kevin Michael CHIEF FINANCIAL OFFICER 2024-02-22 Grant or award +60,000 86,500 D
Loading xslF345X05/form4-02262024_090246.xml…